Project Grant R43DC023832
- Federal Grant Award Summary MSTATT LLC (doing business as North Coast Photonics) received a $306,872 Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD) under the Research Related to Deafness and Communication Disorders program (CFDA 93.173) for the period September 1, 2025, through August 31, 2026. The awardee is developing a safe, low-power digital laser otoscope designed to improve the identification and diagnosis of otitis media with effusion...
- Federal Project Grant Award Summary Glimpse Diagnostics, Inc. received a $3.07 million Project Grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), awarded August 1, 2025, with completion targeted for July 31, 2027. The grant supports validation and commercialization of a deep learning artificial intelligence algorithm designed to diagnose...
- Federal Grant Award Summary The National Institute on Deafness and Other Communication Disorders (NIDCD) awarded a $891,722 Project Grant to the University of Southern California on September 17, 2025, under the Research Related to Deafness and Communication Disorders program (CFDA 93.173). The grant supports development of a low-cost imaging technology for early detection of ear disorders, specifically targeting pathologies affecting the tympanic membrane (TM) such as perforations, retraction...
- Federal Grant Award Summary Restorear Devices LLC received a $307,962 Project Grant from the National Institute on Deafness and Other Communication Disorders (NIDCD) under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), awarded June 17, 2025, with completion targeted for June 30, 2026. The project develops and tests a non-invasive, non-pharmaceutical therapeutic intervention for tinnitus management using mild therapeutic hypothermia (MTH) delivered via the...
- Federal Grant Award Summary Iotamotion, Inc. received a $306,872 Project Grant from the National Institute on Deafness and Other Communication Disorders (NIDCD) under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), awarded on July 15, 2025, with a completion date of June 30, 2027. The company is developing EMOTO, a novel electromagnetic tracking technology designed to improve cochlear implant (CI) surgical outcomes by providing real-time trajectory guidance...
- Federal Grant Award Summary Omnispeech, LLC received a $292,543 Project Grant from the National Institute on Deafness and Other Communication Disorders (NIDCD) under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), effective September 1, 2025 through August 31, 2026. The awardee will develop an AI-based deep learning speech enhancement (SE) algorithm specifically designed for integration into hearing aid chips. Building on Omnispeech's commercially available...
- Federal Project Grant Award Summary Massachusetts Eye And Ear Infirmary received a $655,214 Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD) under the Research Related to Deafness and Communication Disorders program (CFDA 93.173) beginning May 5, 2026 and concluding March 31, 2031. The research project focuses on developing and validating high-frequency bone conduction testing methodologies to address a critical diagnostic gap in...
- Federal Grant Award Summary Vortant Technologies LLC received a $293,512 Project Grant from the National Institute on Deafness and Other Communication Disorders (NIDCD) under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), awarded September 1, 2025, with completion targeted for August 31, 2026. The company will develop and demonstrate feasibility of an innovative binaural beamforming algorithm designed for cochlear implant (CI) processors that improves...
- Federal Project Grant Award Summary The National Institute on Deafness and Other Communication Disorders (NIDCD) awarded $244,740 to the University of California, San Diego under the Research Related to Deafness and Communication Disorders program (CFDA 93.173) on September 30, 2026, with a completion date of June 30, 2029. This project grant funds multidimensional analysis of cochlear pathology in sensorineural hearing loss (SNHL), addressing a significant public health concern by developing...
- Federal Grant Award Summary The National Institute on Deafness and Other Communication Disorders (NIDCD) awarded UC San Diego a Project Grant in the amount of $438,244 under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), effective January 1, 2026 through December 31, 2027. This research initiative focuses on developing human induced pluripotent stem cell (hiPSC)-derived models to investigate the blood-labyrinthine barrier (BLB), a critical vascular...
Federal Grant Award Summary Glimpse Diagnostics, Inc. received a $314,258 Project Grant from the National Institute on Deafness and Other Communication Disorders (NIDCD) under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), awarded June 1, 2026, with completion targeted for May 31, 2027. The grant funds development of closed-loop control algorithms for an adaptive Eustachian tube dysfunction (ETD) treatment device designed to address a significant clinical treatment gap affecting millions of children annually. The device utilizes non-invasive masseter reflex stimulation to trigger the tensor veli palatini muscle and open the Eustachian tube, providing a point-of-care alternative to observation or surgical intervention for pediatric middle ear effusion. The research deliverables include safe Bayesian optimization algorithms and computational modeling systems that automatically discover optimal stimulation parameters without subjecting pediatric patients to prolonged treatment attempts. The technology employs finite element analysis and Gaussian process surrogate models to characterize stimulation-response relationships across the full clinical spectrum of middle ear effusion viscosity (ranging from 1-2 centipoise to 500-2000+ centipoise), while real-time tympanometry feedback enables the closed-loop system to iteratively optimize treatment protocols and converge on optimal parameters within three treatment attempts while maintaining pediatric neuromuscular stimulation safety bounds.